These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11158935)

  • 1. Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
    Gravholt CH; Frystyk J; Flyvbjerg A; Orskov H; Christiansen JS
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E308-14. PubMed ID: 11158935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma insulin-like growth factors (IGFs), IGF-Binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome.
    de Boer L; Hoogerbrugge CM; van Doorn J; van Buul-Offers SC; Karperien M; Wit JM
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):615-27. PubMed ID: 15198293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GH.
    Westwood M; Tajbakhsh SH; Siddals KW; Whatmore AJ; Clayton PE
    Pediatr Res; 2011 Jul; 70(1):25-30. PubMed ID: 21430600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.
    Støving RK; Flyvbjerg A; Frystyk J; Fisker S; Hangaard J; Hansen-Nord M; Hagen C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1346-50. PubMed ID: 10199777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.
    Milewicz T; Krzysiek J; Sztefko K; Radowicki S; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):876-82. PubMed ID: 16821205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C; Silve C; Rosato R; Segovia B; Binoux M
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
    Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
    Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial fluid contains higher in vitro IGF bioactivity than serum: a study utilizing the suction blister technique.
    Espelund U; Søndergaard K; Bjerring P; Flyvbjerg A; Frystyk J
    Growth Horm IGF Res; 2012 Dec; 22(6):234-9. PubMed ID: 22939216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The somatotropin-somatomedin axis in adult patients with Turner syndrome: measurement of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients.
    Holl RW; Kunze D; Blum WF; Benz R; Etzrodt H; Heinze E
    Horm Res; 1993; 39(1-2):30-5. PubMed ID: 7691702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children who fail to thrive.
    Frost RA; Nachman SA; Lang CH; Gelato MC
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2957-62. PubMed ID: 8768858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.